Public Reporting

As required by CMS, the information on this webpage contains our Public Reporting information

ACO Name and Location:

Delaware Valley ACO 259 North Radnor Chester Road Suite 290 Radnor, PA 19087

ACO Primary Contact:

Joel Port portj@dvaco.org 610-225-6295

Organizational Information:

ACO participants:

*Abington Memorial Hospital (Abington-Lansdale Hospital)
Alpha Medical Group, Ltd.
Aria Health Orthopaedics
Aria Health Physician Services
Associated Family Practice Professionals, P.C.
Balmont Family Practice
Bryn Mawr Medical Specialists Association
Christine Meyer, M.D., LLC
Daniel C. Lazowick, D.O., LLC
Delaware Valley Community Health, Inc.
Founders Medical Practice P.C.
Geoffrey W. Temple Family Medical Associates, P.C.
Great Valley Medical Associates PC
Green & Seidner Family Practice Associates Pc
Integrated Health and Wellness Center PC
Internal Medicine Associates PA
Jefferson Medical Care
Jefferson University Physicians
Jefferson University Physicians of New Jersey PC
Jon Yardney, M.D. LLC
Joseph LaBricciosa DO PC
Joseph P. Badolato, D.O., P.C.
Lawrence I Miller D.O., P.C.
Lester J. Groverman, M.D. & Robert J. Braunfeld, D.O. Associates, P.A. (Delaware County Family Practice)
Lewis Family Practice
Lower Merion Family Medicine PC
*Magee Memorial Hospital For Convalescents
Main Line HealthCare
*Main Line Hospitals, Inc. (Bryn Mawr Hospital, Bryn Mawr Rehabilitation Hospital, Lankenau Medical Center, Mirmont Treatment Center, Paoli Hospital, Riddle Hospital)
Mazzoni Center
Methodist Associates in Healthcare, Inc.
Paoli Family Medicine
Peter R Honig
Philadelphia College of Osteopathic Medicine
Pottstown Medical Specialists, Inc.
Project H.O.M.E.
Richard A. Koff MD PC
Rose Tree Medical Associates, LLC
Ross Podell, M.D., P.C.
Smith Medicine, PC
Steiner Medical and Therapeutic Center
Steingard & Testa Medical Associates, P.C.
Suburban Geriatric’s, Inc.
Tara Lyn Cuda DO, PC
*Thomas Jefferson University Hospitals, Inc. (Jefferson Hospital for Neuroscience, Methodist Hospital, Thomas Jefferson University Hospital)
Turnersville Internal Medicine & Geriatrics
University Gastroenterology and Hepatology Associates PC
Western Main Line Medical Associates, LLC
Whitford Family Medicine, P.C.
William Greer
William R. Schetman, M.D., LLC

ACO participants in joint ventures between ACO professionals and hospitals:

Participants involved in a joint venture are identified by the * next to their names on the participant list

ACO governing body:

Stephen Klasko, M.D., Co-Chairman, Voting Member, ACO Participant Representative, Thomas Jefferson University Hospitals, Inc.
John Lynch, III, Co-Chairman, Voting Member, ACO Participant Representative, Main Line Hospitals, Inc.
Christine Arenson, M.D., Voting Member, ACO Participant Representative, Jefferson University Physicians
Elizabeth Balderston, Voting Member, ACO Participant Representative, Main Line Hospitals, Inc.
*Jack Carroll, Non-voting Member, ACO Participant Representative, Magee Memorial Hospital For Convalescents
Peter DeAngelis, Voting Member, ACO Participant Representative, Thomas Jefferson University Hospitals, Inc.
Anne Docimo, M.D., Voting Member, ACO Participant Representative, Jefferson University Physicians
William Greer, M.D., Voting Member, ACO Participant Representative, William Greer, M.D., P.C.
Laurence Merlis, Voting Member, ACO Participant Representative, Thomas Jefferson University Hospitals, Inc.
Andrew Norton, M.D., Voting Member, ACO Participant Representative, Main Line HealthCare
Frank Slattery, Jr., Voting Member, ACO Participant Representative, Main Line Hospitals, Inc.
W. Steven Mark, M.D., Voting Member, Medicare Beneficiary Representative
David Nace, M.D., Voting Member, Community Stakeholder Representative
Katherine Schneider, M.D., Voting Member, Other: ACO President & Chief Executive Officer
*Indicates non-voting Member of ACO Board

Key ACO clinical and administrative leadership:

Katherine Schneider, MD, M.Phil., FAAFP, President and Chief Executive Officer
Mitchell Kaminski, MD, MBA
, Chief Clinical Officer
Joel Port, MHSA, FACHE, CMPE
, Chief Operating Officer

Associated Committees and committee leadership:

Care Coordination Committee Mitchell Kaminski, MD, MBA (Chairman)
Audit and Finance Committee
Michael J. Buongiorno (Chairman)
IT Steering Committee
Robert Kagarise (Chairman)
Network Development Committee
Joel Port (Chairman)

Types of ACO participants, or combination of participants, that formed the ACO:

  • ACO professionals in a group practice arrangement
  • Partnership or joint venture arrangement between hospitals and ACO professionals
  • Hospital employing ACO professionals

Shared Savings and Losses:

Amount of Shared Savings/Losses

Agreement period beginning 2014, Performance Year 2014: $6,567,267
Agreement period beginning 2014, Performance Year 2015: $0

Shared Savings Distribution

Agreement period beginning 2014, Performance Year(s) 2014, 2015

  • Proportion invested in infrastructure: 15%
  • Proportion invested in redesigned care processes/resources: 15%
  • Proportion of distribution to ACO participants: 70%

Payment Rule Waivers:

  • No, our ACO does not utilize the SNF 3-Day Rule Waiver.

Quality Performance Results

Quality Performance Results Table
Measure Number Measure Name 2015 reporting period
ACO performance rate Mean performance rate (SSP- ACOs)
ACO-1 CAHPS: Getting Timely Care, Appointments, and Information 82.10 80.61
ACO-2 CAHPS: How Well Your Providers Communicate 93.48 92.65
ACO-3 CAHPS: Patients’ Rating of Provider 92.53 91.94
ACO-4 CAHPS: Access to Specialists 82.01 83.61
ACO-5 CAHPS: Health Promotion and Education 59.91 59.06
ACO-6 CAHPS: Shared Decision Making 74.95 75.17
ACO-7 CAHPS: Health Status/Functional Status 75.31 72.30
ACO-34 CAHPS: Stewardship of Patient Resources* 23.53 26.87
ACO-8 Risk Standardized, All Condition Readmission 15.15 14.86
ACO-35 Skilled Nursing Facility 30-Day All-Cause Readmission Measure (SNFRM)* Readmission 19.07 18.07
ACO-36 All-Cause Unplanned Admissions for Patients with Diabetes* 61.98 54.60
ACO-37 All-Cause Unplanned Admissions for Patients with Heart Failure* 85.96 76.96
ACO-38 All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions 69.28 62.92
ACO-9 Ambulatory Sensitive Condition Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5) 1.25 1.11
ACO-10 Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8) 1.25 1.04
ACO-11 Percent of Primary Care Physicians who Successfully Meet Meaningful Use Requirements 86.83 76.22
ACO-39 Documentation of Current Medications in the Medical Record* 92.50 84.07
ACO-13 Falls: Screening for Future Fall Risk 49.66 56.46
ACO-14 Preventive Care and Screening: Influenza Immunization 63.42 62.03
ACO-15 Pneumonia Vaccination Status for Older Adults 66.55 63.73
ACO-16 Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-up 60.84 71.15
ACO-17 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention 66.44 90.16
ACO-18 Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan 37.73 45.25
ACO-19 Colorectal Cancer Screening 59.96 60.06
ACO-20 Breast Cancer Screening 76.82 65.67
ACO-21 Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented 37.35 70.04
ACO-40 Depression Remission at Twelve Months* N/A N/A
ACO-27 Diabetes Mellitus: Hemoglobin A1c Poor Control 17.19 20.38
ACO-41 Diabetes: Eye Exam* 51.58 41.05
ACO-28 Hypertension: Controlling High Blood Pressure 62.98 69.62
ACO-30 Ischemic Vascular Disease: Use of Aspirin or Another Antithrombotic 82.09 83.82
ACO-31 Heart Failure: Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) 94.50 87.22
ACO-33 Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy – for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%) 77.71 77.73
CAHPS = Consumer Assessment of Healthcare Providers and Systems, PQI = Prevention Quality Indicator, LVSD = left ventricular systolic dysfunction, ACE = angiotensin-converting enzyme, ARB = angiotensin receptor blocker, CAD = coronary artery disease.
*= Measure required beginning Reporting Year 2015.
N/A= Reporting on the depression remission measure is not required for 2015, as indicated by N/A
2012 – 2014 Quality Measure Reporting Requirements Table
Measure number Performance measure 2012 reporting period 2013 reporting period 2014 reporting period
ACO performance rate Mean performance rate for all ACOs ACO performance rate Mean performance rate for all ACOs ACO performance rate Mean performance rate for all ACOs
ACO #1 Getting Timely Care, Appointments, and Information Not in operation Not in operation Not in operation Not in operation 79.28 80.13
ACO #2 How Well Your Doctors Communicate Not in operation Not in operation Not in operation Not in operation 93.77 92.39
ACO #3 Patients’ Rating of Doctor Not in operation Not in operation Not in operation Not in operation 92.44 91.58
ACO #4 Access to Specialists Not in operation Not in operation Not in operation Not in operation 82.41 83.97
ACO #5 Health Promotion and Education Not in operation Not in operation Not in operation Not in operation 60.93 58.29
ACO #6 Shared Decision Making Not in operation Not in operation Not in operation Not in operation 76.32 74.60
ACO #7 Health Status/Functional Status Not in operation Not in operation Not in operation Not in operation 71.63 71.10
ACO #8 Risk Standardized, All Condition Readmissions Not in operation Not in operation Not in operation Not in operation 15.58 15.15
ACO #9 ASC Admissions: COPD or Asthma in Older Adults Not in operation Not in operation Not in operation Not in operation 1.23 1.08
ACO #10 ASC Admission: Heart Failure Not in operation Not in operation Not in operation Not in operation 1.59 1.19
ACO #11 Percent of PCPs who Qualified for EHR Incentive Payment Not in operation Not in operation Not in operation Not in operation 82.43 76.71
ACO #12 Medication Reconciliation Not in operation Not in operation Not in operation Not in operation 46.36 82.61
ACO #13 Falls: Screening for Fall Risk Not in operation Not in operation Not in operation Not in operation 27.81 45.60
ACO #14 Influenza Immunization Not in operation Not in operation Not in operation Not in operation 36.18 57.51
ACO #15 Pneumococcal Vaccination Not in operation Not in operation Not in operation Not in operation 34.59 55.03
ACO #16 Adult Weight Screening and Follow-up Not in operation Not in operation Not in operation Not in operation 61.66 66.75
ACO #17 Tobacco Use Assessment and Cessation Intervention Not in operation Not in operation Not in operation Not in operation 78.60 86.79
ACO #18 Depression Screening Not in operation Not in operation Not in operation Not in operation 7.01 39.27
ACO #19 Colorectal Cancer Screening Not in operation Not in operation Not in operation Not in operation 41.46 56.14
ACO #20 Mammography Screening Not in operation Not in operation Not in operation Not in operation 44.06 61.41
ACO #21 Proportion of Adults who had blood pressure screened in past 2 years Not in operation Not in operation Not in operation Not in operation 58.47 60.24
ACO #22 Hemoglobin A1c Control (HbA1c) (<8 percent) Not in operation Not in operation Not in operation Not in operation 44.64 Not applicable
ACO #23 Low Density Lipoprotein (LDL) (<100 mg/dL) Not in operation Not in operation Not in operation Not in operation Not applicable Not applicable
ACO #24 Blood Pressure (BP) <140/90 Not in operation Not in operation Not in operation Not in operation 72.49 Not applicable
ACO #25 Tobacco Non Use Not in operation Not in operation Not in operation Not in operation 72.66 Not applicable
ACO #26 Aspirin Use Not in operation Not in operation Not in operation Not in operation 81.52 Not applicable
ACO #27 Percent of beneficiaries with diabetes whose HbA1c in poor control (>9 percent) Not in operation Not in operation Not in operation Not in operation 48.62 20.35
ACO #28 Percent of beneficiaries with hypertension whose BP <140/90 Not in operation Not in operation Not in operation Not in operation 71.67 68.02
ACO #29 Percent of beneficiaries with IVD with complete lipid profile and LDL control <100mg/dl Not in operation Not in operation Not in operation Not in operation Not applicable Not applicable
ACO #30 Percent of beneficiaries with IVD who use Aspirin or other antithrombotic Not in operation Not in operation Not in operation Not in operation 83.72 80.79
ACO #31 Beta-Blocker Therapy for LVSD Not in operation Not in operation Not in operation Not in operation 94.39 82.71
ACO #32 Drug Therapy for Lowering LDL Cholesterol Not in operation Not in operation Not in operation Not in operation Not applicable Not applicable
ACO #33 ACE Inhibitor or ARB Therapy for Patients with CAD and Diabetes and/or LVSD Not in operation Not in operation Not in operation Not in operation 72.34 Not applicable
Note: ASC = ambulatory sensitive conditions, COPD = chronic obstructive pulmonary disease, PCP = primary care physician, EHR = electronic health record, IVD = ischemic vascular disease, LVSD = left ventricular systolic dysfunction, ACE = angiotensin-converting enzyme, ARB = angiotensin receptor blocker, CAD = coronary artery disease.

For more information on how to interpret scores on the above quality performance measures, see https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/sharedsavingsprogram/Downloads/MSSP-QM-Benchmarks.pdf

Contact Information

Address PO Box 356, Villanova, PA 19085
Phone 610-225-6295
Toll Free Number 855-761-9345
TTY# 610-225-6275
Compliance Line 610-225-6211
Email dvacomail@dvaco.org
Business Hours 9-5pm

Email Us*

*Please do not use the above form for medical questions and/or for an emergency. For medical questions, please contact your physician, and for emergencies please call 911.